Literature DB >> 2409964

Effective DNA cleavage by bleomycin-vanadium(IV) complex plus hydrogen peroxide.

J Kuwahara, T Suzuki, Y Sugiura.   

Abstract

It has been firstly found that the bleomycin-vanadyl(IV) complex is effectively capable of cleaving DNA in the presence of hydrogen peroxide. The 1:1 bleomycin-VO(IV) complex has been characterized by ESR and electronic absorption spectra, and its ESR parameters (go = 1.982 and Ao = 93.5 G) are indicative of VO(N5) coordination type for the metal-binding environment. The mode of nucleotide sequence cleavage induced by the present bleomycin-VO(IV)-H2O2 complex system was appreciably different from the corresponding Fe(III) complex system. Of special interest is the fact that the bleomycin-vanadium complex system more preferentially attacked G-A(5'----3') sequences than the bleomycin-iron complex system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409964     DOI: 10.1016/0006-291x(85)90160-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Mechanisms of bleomycin-induced lung damage.

Authors:  J Hay; S Shahzeidi; G Laurent
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

2.  DNA modification by oxovanadium(IV) complexes of salen derivatives.

Authors:  Géraldine Verquin; Gaëlle Fontaine; Marc Bria; Elena Zhilinskaya; Edmond Abi-Aad; Antoine Aboukaïs; Brigitte Baldeyrou; Christian Bailly; Jean-Luc Bernier
Journal:  J Biol Inorg Chem       Date:  2004-03-13       Impact factor: 3.358

3.  Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.

Authors:  Alvin A Holder; Patrick Taylor; Anthony R Magnusen; Erick T Moffett; Kyle Meyer; Yiling Hong; Stuart E Ramsdale; Michelle Gordon; Javelyn Stubbs; Luke A Seymour; Dhiraj Acharya; Ralph T Weber; Paul F Smith; G Charles Dismukes; Ping Ji; Laura Menocal; Fengwei Bai; Jennie L Williams; Donald M Cropek; William L Jarrett
Journal:  Dalton Trans       Date:  2013-09-07       Impact factor: 4.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.